Answers are grounded in this paper and cite their sources.
Migraines are one of the most prevalent neurological disorders worldwide and a leading cause of disability among young and middle-aged adults. Although its pathophysiology is complex and multifactorial, accumulating evidence suggests that oxidative stress, neuroinflammation, and metabolic dysregulation play central roles in disease development. Bilirubin, traditionally regarded as a potentially toxic end-product of heme catabolism, is now increasingly recognized as a biologically active molecule with potent antioxidant, anti-inflammatory, and neuroprotective properties. Through the biliverdin reductase–bilirubin axis, bilirubin contributes to redox homeostasis, modulates inflammatory signaling pathways, and protects neural tissues from oxidative injury. Recent clinical and epidemiological studies have consistently demonstrated lower serum bilirubin concentrations in patients with migraine compared with healthy controls. These findings have been observed across diverse populations, including children, adolescents, and adults, and are further supported by large population-based analyses showing an inverse association between circulating bilirubin levels and migraine prevalence. Emerging genetic evidence additionally suggests that liver-related metabolic pathways involving bilirubin, aspartate aminotransferase (AST), and γ-glutamyltransferase (GGT) may contribute to migraine susceptibility through mechanisms related to oxidative stress, neuroinflammation, and structural brain alterations. This review summarizes current evidence regarding the relationship between bilirubin and migraine, focusing on the biological mechanisms that may underlie this association. We discuss the neuroprotective functions of bilirubin, the role of oxidative stress and neuroinflammation in migraine pathogenesis, and the growing evidence supporting the liver–brain axis as a novel conceptual framework linking hepatic metabolism with neurological disease. We also review clinical and genetic studies investigating bilirubin as a potential biomarker of migraine susceptibility.
No takes yet. Share an insight, caveat, or question.
Wściślak et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: